Medpace Holdings (MEDP) Tops Q4 EPS by 24c ; Offers Guidance

Medpace Holdings (NASDAQ: MEDP) reported Q4 EPS of $2.46, $0.24 better than the analyst estimate of $2.22. Revenue for the quarter came in at $498.4 million versus the consensus estimate of $498.84 million.

GUIDANCE:

Medpace Holdings sees FY2024 revenue of $2.15-2.2 billion, versus the consensus of $2.18 billion.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• SanDisk upgraded at JPMorgan after investor day; shares climb